Buffering capacity of bovine vitreous

Retina

Volumn 28, Issue 1, 2008, Pages 150-153

  Conway, Mandi D ^a,b   Jermak, Christopher M ^a   Peyman, Gholam A ^a,b   Swanson, Harvey T ^a   Blake, Diane A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Acid; Base; Buffering capacity; Triamcinolone acetonide; Vitreous

Indexed keywords

HYDROCHLORIC ACID; SODIUM CHLORIDE; SODIUM HYDROXIDE; TRIAMCINOLONE ACETONIDE;

ACIDITY; ALKALINITY; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; DRUG FORMULATION; FLOW RATE; NONHUMAN; PH; TIME; VITREOUS BODY;

ANIMALS; BUFFERS; CATTLE; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; SODIUM HYDROXIDE; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 38049152913     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31806dafb7     Document Type: Article

References (16)

1. Peyman GA, Moshfeghi DM. Intravitreal triamcinolone acetonide. Retina 2004;24:488-490.
2. Peyman GA, Cheema R, Conway MD, et al. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000;20:554-555.
3. Moore J, Jurs P, Stanitski C. Chemistry: The Molecular Science. 2nd Ed. Belmont: Thompson Brooks/Cole; 2005.
4. Sebag J. Structure, function, and age-related changes of the human vitreous. In: Schepens CL, Neetens A, eds. The Vitreous and Vitreoretinal Interface. New York: Springer-Verlag; 1987:37-57.
5. Balazx EA. The vitreous. Int Ophthalmol Clin 1973;13:169-187.
6. Blomdahl S. Ultrasonic measurements of the eye in the newborn infant. Acta Ophthalmol 1979;57:1048-1056.
7. Pirie A, Schmidt G, Waters JW. Ox vitreous humour. I. The residual protein. Br J Ophthalmol 1948;32:321-339.
8. Balazs EA, Laurent TC, Laurent UBG. Studies on the structure of the vitreous body. VI. Biochemical changes during development. J Biol Chem 1959;234:422-430.
9. Sebag J. Ageing of the vitreous. Eye 1987;1:254-262.
10. Tolentino FI, Schepens CL, Freeman HM. Vitreoretinal Disorders: Diagnosis and Management. Philadelphia: WB Saunders; 1976:226.
11. Murakami K, Jalkh AE, Avila MP, et al. Vitreous floaters. Ophthalmology 1983;90:1271-1276.
12. Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 1987;225:89-93.
13. Pruett RC, Albert DM. Vitreous degeneration in myopia and retinitis pigmentosa. In: Schepens CL, Neetens A, eds. The Vitreous and Vitreoretinal Interface. New York: Springer-Verlag; 1987:211-228.
14. Schulman J, Merin S. Hereditary vitreoretinal degenerations. In: Newsome DA, ed. Retinal Dystrophies and Degenerations. New York: Raven Press; 1988:85-104.
15. Blair NP, Albert DM, Liberfarb RM, et al. Hereditary progressive arthro-ophthalmopathy of Stickler. Am J Ophthalmol 1979;88:876-888.
16. Daily MJ, Peyman GA, Fishman G. Intravitreal injection of methicillin for treatment of endophthalmitis. Am J Ophthalmol 1973;76:343-350.